Orphan Cholestatic Liver Diseases

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Orphan Cholestatic Liver Diseases trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 1

NCT03082937

An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects

The primary objectives of the study are to assess the mass balance recovery after a single dose of carbon-14 \[14C\]-A4250 as a capsule and to provide plasma, u…

United Kingdom6 participantsStarted 2017-01-31

Treatment: 3 mg [14C]-A4250 capsule

CompletedPhase 1

NCT02963077

A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384

The primary objectives of the study are to evaluate the safety, tolerability and pharmacokinetics of A4250 after single or multiple oral doses in healthy subjec…

Location not specified94 participantsStarted 2013-07

Treatment: A4250, CRC (A3384)